Pharming (PHAR) Gross Margin (QoQ) (2020 - 2026)

Pharming (PHAR) Gross Margin (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Pharming 9.02 Bn 8.96 Bn 65.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1,064.00
Dec 31, 2025 -1,252.00
Sep 30, 2025 274.00
Jun 30, 2025 49.00
Mar 31, 2025 82.00
Dec 31, 2024 -225.00
Sep 30, 2024 353.00
Jun 30, 2024 247.00
Mar 31, 2024 -17,980,295.57 Bn
Dec 31, 2023 17,980,295.57 Bn
Sep 30, 2023 -5.05 Bn
Jun 30, 2023 5.05 Bn
Mar 31, 2023 -210.00
Dec 31, 2022 -324.00
Sep 30, 2022 374.00
Jun 30, 2022 253.00
Mar 31, 2022 14,964.00
Dec 31, 2021 -14,880.00
Sep 30, 2021 -212.00
Jun 30, 2021 200.00